Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE – Get Free Report) shares gapped up before the market opened on Wednesday after the company announced better than expected quarterly earnings. Ultragenyx Pharmaceutical shares last traded at $25.43, with a volume of 406,705 shares traded. Get Ultragenyx Pharmaceutical alerts:Ultragenyx Pharmaceutical News SummaryHere are the key news stories impacting Ultragenyx Pharmaceutical this week:Analysts Set New Price TargetsA number of equities analysts recently issued reports on the stock. Wall Street Zen raised shares of Ultragenyx Pharmaceutical from a “strong sell” rating to a “sell” rating in a report on Saturday, June 6th. Featured ArticlesReceive News & Ratings for Ultragenyx Pharmaceutical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ultragenyx Pharmaceutical and related companies with MarketBeat.com's FREE daily email newsletter.